Trontinemab: Clinical Trials

3 active not recruiting, 1 recruiting. 3 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	3	Active not recruiting 2, Recruiting 1
Phase 1	1	Active not recruiting 1
Phase 2	1	Active not recruiting 1

Follow Trontinemab: new trials by email Literature Review of Trontinemab trials Research Report on Trontinemab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimer's Disease	Phase 3	Recruiting	Hoffmann-La Roche	1600	2026-10-02	2026-11-06
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimers Disease	Phase 3	Active not recruiting	Hoffmann-La Roche	1060	2025-11-12	2026-09-25
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Trontinemab, Placebo - Alzheimers Disease	Phase 3	Active not recruiting	Hoffmann-La Roche	1101	2025-09-17	2026-09-25
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease RO7126209, Placebo - Alzheimers Disease	Phase 1 / Phase 2	Active not recruiting	Hoffmann-La Roche	241	2021-03-15	2026-09-14

Conditions studied

Alzheimer Disease (4)  ·  Cognitive Dysfunction (2)

Sponsors

Hoffmann-La Roche (4)

Countries

Canada (4)  ·  Japan (4)  ·  United Kingdom (4)  ·  United States (4)  ·  Argentina (3)  ·  Australia (3)  ·  Brazil (3)  ·  Poland (3)  ·  Spain (3)  ·  Chile (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  South Korea (2)

NIH funding

2023 (1)